CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
ConditionAlopecia Areata
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorEvitas
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner.
Is at least 18 years of age or older.
Is willing to provide Personal Information.
Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.
None